Robinson L, Feting A, Isozaki I, Seyfert-Morgolis V, Jay M, Kim E
BMJ Open. 2025; 15(2):e084408.
PMID: 39987006
PMC: 11848656.
DOI: 10.1136/bmjopen-2024-084408.
Garrett N, Reddy T, Yende-Zuma N, Takalani A, Woeber K, Bodenstein A
PLOS Glob Public Health. 2024; 4(12):e0003260.
PMID: 39636838
PMC: 11620404.
DOI: 10.1371/journal.pgph.0003260.
Nguyen D, Hentenaar I, Morrison-Porter A, Solano D, Haddad N, Castrillon C
Nat Med. 2024; 31(1):235-244.
PMID: 39333316
PMC: 11750719.
DOI: 10.1038/s41591-024-03278-y.
Cao X, Xie Y, Yi J, Liu Z, Zhang D, Yue Y
Front Cardiovasc Med. 2024; 11:1401586.
PMID: 39131705
PMC: 11310024.
DOI: 10.3389/fcvm.2024.1401586.
Li Y, Tao X, Ye S, Tai Q, You Y, Huang X
Viruses. 2024; 16(7).
PMID: 39066192
PMC: 11281602.
DOI: 10.3390/v16071029.
Defining Incidental Versus Non-incidental COVID-19 Hospitalizations.
Nikolla D, Oskvarek J, Zocchi M, Rahman N, Leubitz A, Moghtaderi A
Cureus. 2024; 16(3):e56546.
PMID: 38646211
PMC: 11027788.
DOI: 10.7759/cureus.56546.
Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron.
Zhang X, Luo F, Zhang H, Guo H, Zhou J, Li T
JCI Insight. 2024; 9(7).
PMID: 38587080
PMC: 11128199.
DOI: 10.1172/jci.insight.171034.
Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study.
Funk A, Florin T, Kuppermann N, Finkelstein Y, Kazakoff A, Baldovsky M
Clin Infect Dis. 2024; 78(6):1522-1530.
PMID: 38530249
PMC: 11175701.
DOI: 10.1093/cid/ciae069.
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
Townsley H, Gahir J, Russell T, Greenwood D, Carr E, Dyke M
PLoS One. 2024; 19(3):e0294897.
PMID: 38512960
PMC: 10956747.
DOI: 10.1371/journal.pone.0294897.
Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review.
Duan C, Liu L, Wang T, Wang G, Jiang Z, Li H
BMC Med. 2024; 22(1):116.
PMID: 38481207
PMC: 10938697.
DOI: 10.1186/s12916-024-03334-x.
Generalizing the Use of a Procalcitonin-Guided Antibiotic Algorithm to a New Era of SARS-CoV-2 Infection.
Walker M, Kadri S
Chest. 2024; 165(3):e85-e86.
PMID: 38461024
PMC: 11075174.
DOI: 10.1016/j.chest.2023.10.041.
Silent battles: immune responses in asymptomatic SARS-CoV-2 infection.
Bert N, Samandari T
Cell Mol Immunol. 2024; 21(2):159-170.
PMID: 38221577
PMC: 10805869.
DOI: 10.1038/s41423-024-01127-z.
The effectiveness and efficiency of asymptomatic SARS-CoV-2 testing strategies for patient and healthcare workers within acute NHS hospitals during an omicron-like period.
Evans S, Naylor N, Fowler T, Hopkins S, Robotham J
BMC Infect Dis. 2024; 24(1):64.
PMID: 38191324
PMC: 10775431.
DOI: 10.1186/s12879-023-08948-9.
Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria.
Chalupka A, Richter L, Chakeri A, El-Khatib Z, Theiler-Schwetz V, Trummer C
Eur J Clin Invest. 2023; 54(3):e14136.
PMID: 38032853
PMC: 11475503.
DOI: 10.1111/eci.14136.
Epidemiological and Genomic Analysis of Asymptomatic SARS-CoV-2 Infections during the Delta and Omicron Epidemic Waves in São Paulo City, Brazil.
Slavov S, Lima A, Ribeiro G, de Lima L, Barros C, Marqueze E
Viruses. 2023; 15(11).
PMID: 38005887
PMC: 10675288.
DOI: 10.3390/v15112210.
SARS-CoV-2 seroprevalence and associated factors, based on HIV serostatus, in young people in Sofala province, Mozambique.
Benoni R, Casigliani V, Zin A, Giannini D, Ronzoni N, Di Chiara C
BMC Infect Dis. 2023; 23(1):809.
PMID: 37978353
PMC: 10656907.
DOI: 10.1186/s12879-023-08808-6.
Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts.
Zeng T, Lu Y, Zhao Y, Guo Z, Sun S, Teng Z
Respir Res. 2023; 24(1):246.
PMID: 37828565
PMC: 10571409.
DOI: 10.1186/s12931-023-02542-y.
A comparative study of compartmental models for COVID-19 transmission in Ontario, Canada.
Zhao Y, Wong S
Sci Rep. 2023; 13(1):15050.
PMID: 37700081
PMC: 10497623.
DOI: 10.1038/s41598-023-42043-y.
Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey.
Qin S, Li Y, Wang L, Zhao X, Ma X, Gao G
Emerg Microbes Infect. 2023; 12(2):2258232.
PMID: 37691586
PMC: 10512888.
DOI: 10.1080/22221751.2023.2258232.
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.
Motsoeneng B, Manamela N, Kaldine H, Kgagudi P, Hermanus T, Ayres F
Front Immunol. 2023; 14:1231276.
PMID: 37600825
PMC: 10435738.
DOI: 10.3389/fimmu.2023.1231276.